BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS




Industry
Pharmaceutical

Segment
Start Up





 Company News
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data On Multiple Anti-Cancer Stem Cell Programs At American Association for Cancer Research Annual Meeting 4/8/2014 7:30:23 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) Announces Full Year And Fourth Quarter 2013 Financial Results 3/18/2014 8:44:42 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) To Present Data On Anti-Cancer Stem Cell Candidates At The American Association for Cancer Research Meeting 3/6/2014 9:24:00 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Cowen And Company 34th Annual Health Care Conference 2/28/2014 9:57:19 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) Commences Third Phase 1b Clinical Trial For OMP-54F28 (Fzd8-Fc) With Carboplatin And Paclitaxel In Ovarian Cancer 2/20/2014 9:13:41 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Second Phase 1b Clinical Trial For OMP-54F28 (Fzd8-Fc) With Sorafenib (Nexavar®) In Hepatocellular Cancer 2/18/2014 8:57:03 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) Granted Fourth RSPO-LGR Pathway Patent In U.S. 2/3/2014 9:01:45 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) To Present At Two Investor Conferences In February 1/27/2014 8:51:53 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data From Demcizumab Phase 1b Clinical Study In Pancreatic Cancer At The 2014 Gastrointestinal Cancers Symposium 1/17/2014 9:08:58 AM    More...
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data From The Phase 1b Portion Of The ALPINE Clinical Study Of OMP-59R5 In Pancreatic Cancer At The 2014 Gastrointestinal Cancers Symposium 1/17/2014 9:07:07 AM    More...
12345678